Automated analysis of co-localized protein expression in histologic sections of prostate cancer.
Thomas A TennillMitchell E GrossHermann B FrieboesPublished in: PloS one (2017)
An automated approach based on routinely-processed, whole-slide immunohistochemistry (IHC) was implemented to study co-localized protein expression in tissue samples. Expression of two markers was chosen to represent stromal (CD31) and epithelial (Ki-67) compartments in prostate cancer. IHC was performed on whole-slide sections representing low-, intermediate-, and high-grade disease from 15 patients. The automated workflow was developed using a training set of regions-of-interest in sequential tissue sections. Protein expression was studied on digital representations of IHC images across entire slides representing formalin-fixed paraffin embedded blocks. Using the training-set, the known association between Ki-67 and Gleason grade was confirmed. CD31 expression was more heterogeneous across samples and remained invariant with grade in this cohort. Interestingly, the Ki-67/CD31 ratio was significantly increased in high (Gleason ≥ 8) versus low/intermediate (Gleason ≤7) samples when assessed in the training-set and the whole-tissue block images. Further, the feasibility of the automated approach to process Tissue Microarray (TMA) samples in high throughput was evaluated. This work establishes an initial framework for automated analysis of co-localized protein expression and distribution in high-resolution digital microscopy images based on standard IHC techniques. Applied to a larger sample population, the approach may help to elucidate the biologic basis for the Gleason grade, which is the strongest, single factor distinguishing clinically aggressive from indolent prostate cancer.
Keyphrases
- prostate cancer
- high throughput
- deep learning
- radical prostatectomy
- high resolution
- machine learning
- convolutional neural network
- poor prognosis
- high grade
- optical coherence tomography
- end stage renal disease
- neoadjuvant chemotherapy
- newly diagnosed
- bone marrow
- ejection fraction
- virtual reality
- single cell
- working memory
- squamous cell carcinoma
- mass spectrometry
- radiation therapy
- long non coding rna
- low grade
- hodgkin lymphoma
- patient reported outcomes